INCY vs PAYX
Incyte Corp. and Paychex Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | INCY | PAYX |
|---|---|---|
| Revenue | $5.1B | $6.5B |
| Net income | $1.3B | $1.8B |
| Gross margin | 92.8% | 74.3% |
| Net margin | 25.0% | 27.0% |
| Return on equity | 29.9% | 44.8% |
| Diluted EPS | $6.41 | $4.89 |
| Dividend / share | · | $4.43 |
| Payout ratio | · | 90.3% |
| Free cash flow | · | $2.3B |
| Equity | $5.2B | $3.7B |
| Net debt / equity | · | 0.93× |
| Current ratio | 3.32× | 1.26× |
| Revenue CAGR 5y | 14.0% | 9.9% |
| Profit CAGR 5y | · | · |
PAYX bills 1.3× the revenue of INCY, and keeps more of each dollar of revenue as profit (27.0% against 25.0%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | INCY | PAYX |
|---|---|---|
| FY2025 | $5.1B | $6.5B |
| FY2024 | $4.2B | $5.6B |
| FY2023 | $3.7B | $5.3B |
| FY2022 | $3.4B | $5.0B |
| FY2021 | $3.0B | $4.6B |
| FY2020 | $2.7B | $4.1B |
| FY2019 | $2.2B | $4.0B |
| FY2018 | $1.9B | $3.8B |
| FY2017 | $1.5B | $3.4B |
| FY2016 | $1.1B | $3.2B |
Bottom line
| Fiscal year | INCY | PAYX |
|---|---|---|
| FY2025 | $1.3B | $1.8B |
| FY2024 | $32.6M | $1.7B |
| FY2023 | $597.6M | $1.7B |
| FY2022 | $340.7M | $1.6B |
| FY2021 | $948.6M | $1.4B |
| FY2020 | $-295.7M | $1.1B |
| FY2019 | $446.9M | $1.1B |
| FY2018 | $109.5M | $1.0B |
| FY2017 | $-313.1M | $994.1M |
| FY2016 | $104.2M | $826.3M |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$1,370,758,000 | PAYX |
| FY2024 | −$1,330,483,000 | PAYX |
| FY2023 | −$1,582,651,000 | PAYX |
| FY2022 | −$1,612,465,000 | PAYX |
| FY2021 | −$1,625,433,000 | PAYX |
| FY2020 | −$1,390,098,000 | PAYX |
| FY2019 | −$1,881,741,000 | PAYX |
| FY2018 | −$1,890,617,000 | PAYX |
| FY2017 | −$1,841,484,000 | PAYX |
| FY2016 | −$2,047,281,000 | PAYX |
| FY2015 | −$2,198,149,000 | PAYX |
| FY2014 | −$2,228,105,000 | PAYX |
| FY2013 | −$2,163,953,000 | PAYX |
| FY2012 | −$2,029,141,000 | PAYX |
| FY2011 | −$2,135,345,000 | PAYX |
| FY2010 | −$1,914,422,000 | PAYX |
| FY2009 | −$1,991,535,000 | PAYX |
PAYX has reported the higher revenue in every one of these 17 fiscal years. The gap has narrowed since the earliest year compared.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
5 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −2.0 pp | PAYX |
| FY2024 | −29.0 pp | PAYX |
| FY2023 | −15.9 pp | PAYX |
| FY2022 | −21.1 pp | PAYX |
| FY2021 | +1.6 pp | INCY |
The higher net margin has changed hands between INCY and PAYX over this period.
5 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
INCY's net margin has been more volatile than PAYX's over the 5 comparable fiscal years — 10.9 percentage points of standard deviation against 1.7.
5 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between INCY and PAYX over these 5 fiscal years — INCY led in 1 and PAYX in 4.
5 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
INCY's return on equity has been more volatile than PAYX's over the 10 comparable fiscal years — 19.3 percentage points of standard deviation against 2.9.
10 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
PAYX led in return on equity in every one of the 10 comparable fiscal years — a structural lead, not a recent swing.
10 of 19 comparable fiscal years — a year missing data on either side is not counted.